生命科学资讯

Biopharma CEO optimism is wavering in the US

Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump

Trump to test ‘most favored nation’ pricing for Medicare; Shionogi pays $2.5B for ALS drug

Radiopharmaceutical specialist Aktis seeks an IPO

Cytokinetics set to battle Bristol Myers as FDA approves heart drug

Patient deaths put Merck, Daiichi’s ADC trial on partial hold

BioMarin to buy rare disease drugmaker Amicus for $4.8B

Novo files for CagriSema approval; Merck and Pfizer’s trial win

Galapagos TYK2 drug hits goal in one trial, misses in another

Moderna gets funding for H5 pandemic influenza vaccine

Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial

Insmed’s ‘win streak’ ends as top drug fails study in chronic nasal condition

Takeda says $4B TYK2 drug succeeds in large psoriasis studies

Orum, a biotech marrying ADCs with protein degraders, captures $100M in funding

FDA clears GSK’s twice-yearly asthma drug

Peanut allergy patch succeeds in late-stage study 5 years after FDA rejection

RA Capital backs drug for rare kind of chronic pain

Addition emerges with $100M to make gene therapies for chronic and rare diseases

Developing a path forward in cancer cachexia

Nektar sees silver lining as autoimmune drug ‘narrowly’ misses in alopecia study